We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: A substance in the blood increases before diagnosis of pancreatic cancer (Photo courtesy of Pexels)

Blood Test for Protein Biomarker Could Detect Pancreatic Cancer at Very Early Stage

A new study has found that in some people diagnosed with pancreatic cancer, levels of a particular substance in their blood can be seen to start rising slowly as early as two years before the cancer was diagnosed. This raises the possibility for future research to find ways to detect the dreaded cancer earlier. More...
02 Dec 2022
Image: Liquid biopsies could predict survival odds for patients with metastatic cancer (Photo courtesy of Michigan Medicine)

Blood Tests Could Predict Survival Odds for Patients with Metastatic Cancer

A new study has found that measuring the amount of DNA that has been shed by a tumor compared to the body’s typical amount of DNA, defined as the tumor fraction, may be a new tool to predict survival and guide treatment discussions for patients whose cancer has spread from the breast, prostate, lung or colon. More...
30 Nov 2022
Image: PepSeq is a fully in vitro platform for highly multiplexed serology using customizable DNA-barcoded peptide libraries (Photo courtesy of Northern Arizona University)

New Serological Test Could Search for Viral Triggers of Diseases

A new serological test can not only help humanity prepare for and respond to the next pandemic, but it also can be pivotal in the search for viral triggers of diseases like diabetes and celiac disease.  More...
30 Nov 2022
Image: Juno HAZEL is an innovative solution to increase accessibility and affordability of NIPS (Photo courtesy of Juno Diagnostics)

Blood-Based NIPS Test Improves Access to Genetic Testing

Juno Diagnostics (San Diego, CA, USA) has launched Juno Hazel, a non-invasive prenatal screening (NIPS) solution enabled from finger-prick amounts of blood. More...
29 Nov 2022
Image: Corticobasal degeneration (CBD): diagram of the basal ganglia (in red) and related structures (in blue) within the brain. Basal ganglia along with cerebral cortex are involved in this condition (Photo courtesy of Wikimedia Commons)

Two Tau Variants Distinguish Corticobasal Degeneration from Other Tauopathies

Biomarkers have been found that identify, with up to 89% accuracy, individuals with the primary tauopathy, corticobasal degeneration. More...
28 Nov 2022
Image: A cheap blood test could improve diagnosis of myocarditis (Photo courtesy of Queen Mary University of London)

First-Ever Blood Test Could Detect Deadly Heart Inflammation Within Hours

Myocarditis, or inflammation of the heart muscle, is a difficult condition to diagnose. Now, the discovery of a molecular signal in the blood could pave the way for the first blood test to be used for diagnosing myocarditis within as little as a year. More...
25 Nov 2022
Image: UriFind is a urine-based, non-invasive molecular test for detection of bladder cancer (Photo courtesy of Pexels)

Urine-Based, Non-Invasive Molecular Test Accurately Detects Bladder Cancer

A new study aims to evaluate the performance of a non-invasive, quantitative real-time PCR (qPCR) assay designed to detect two DNA methylation biomarkers in urine specimens from patients suspected of having bladder cancer. More...
25 Nov 2022
New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Clostridium Difficile Test
VIDITEST C. Difficile Toxin A+B (Card) Rapid Test
New
Anti-Rubella IgG (Rubella IgG) Test
Rubella IgG AccuBind ELISA


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
CELLAVISION AB